The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Plasma lipoproteins: genetic influences and clinical implications
Abstract
Susceptibility to the growing global public health problem of cardiovascular disease is associated with levels of plasma lipids and lipoproteins. Several experimental strategies have helped us to clarify the genetic architecture of these complex traits, including classical studies of monogenic dyslipidaemias, resequencing, phenomic analysis and, more recently, genome-wide association studies and analysis of metabolic networks. The genetic basis of plasma lipoprotein levels can now be modelled as a mosaic of contributions from multiple DNA sequence variants, both rare and common, with varying effect sizes. In addition to filling gaps in our understanding of plasma lipoprotein metabolism, the recent genetic advances will improve our ability to classify, diagnose and treat dyslipidaemias.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“elevated plasma LDL-C and TG levels are major risk factors (Defesche et al., 2017; Do et al., 2013; Hegele, 2009; Hokanson and Austin, 1996; Rader, 2016)”
From GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis (2019) · cites this paper as Hegele, 2009
In the citing paper
“In humans and mice, genetic APOB variants associated with increased levels of apoB are also associated with unusually high plasma concentrations of cholesterol and LDL, which in turn contribute to hypercholesterolemia and heart disease in humans (Benn, 2009; Hegele, 2009).”
From Population genomics reveal recent speciation and rapid evolutionary adaptation in polar bears (2014) · cites this paper as Hegele, 2009
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
Global variation in copy number in the human genome
Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H., Andrews, T. D., Fiegler, H., Shapero, M. H., Carson, A. R., Chen, W., et al. (2006) · Nature · doi:10.1038/nature05329 · Cited by 4,377
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G. G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,818
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 472
Zeng, C., Liu, S., Li, H., & Han, X. W. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1644677 · Cited by 4
Dyslipidemia management in stroke prevention: An individualized approach
Stefanou, M., Panagiotopoulos, E., Liberopoulos, E. N., Milionis, H. J., Theodorou, A., Mira, K., de Sousa, D. A., Palaiodimou, L., Vlachopoulos, C., Siasos, G., et al. (2026) · International Journal of Stroke · doi:10.1177/17474930261418388 · Cited by 4
Wang, H., Li, L., Wu, J., Yuan, X., Hong, L., Pu, L., Qin, S., Li, L., Yang, H., & Zhang, J. (2025) · Poultry Science · doi:10.1016/j.psj.2025.105275 · Cited by 4
Extracellular Particles to Track Cancer Biomarkers from Tissue to Biofluids
Nguyen, K. T., Xia, J., Chang, C., Ghosh, A., Hade, M. D., Rima, X. Y., An, J. Y., Oh, S., Min, B. H., Nagaraj, C. K., et al. (2025) · Journal of Dental Research · doi:10.1177/00220345251397369 · Cited by 4
Martín-Campos, J. M. (2021) · Biomedicines · doi:10.3390/biomedicines9111728 · Cited by 4
Walker, C. G., & Jebb, S. A. (2012) · Current Nutrition Reports · doi:10.1007/s13668-012-0017-z · Cited by 4
Influence of Moringa oleifera flaxseed oil and atorvastatin on hyperlipidemic male albino rats
Abdelhalim, S., Hegazi, M. M., & El-Bagoury, M. (2019) · Journal of Cancer and Biomedical Research · doi:10.21608/jcbr.2019.37772 · Cited by 4
Amelioration of murine experimental colitis using biocompatible cyclosporine A lipid carriers
Scarcello, E., Abdel-Mottaleb, M. M. A., Béduneau, A., Moulari, B., & Pellequer, Y. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00835-z · Cited by 4
Bressan, M. C., Belo, A. T., Amaral, A. J., Cordeiro, D., Boari, C. A., Bettencourt, C., van Harten, S., Moreira, O. C., Gama, L. T., & Almeida, J. M. (2021) · Livestock Science · doi:10.1016/j.livsci.2021.104810 · Cited by 4
Abu‐Farha, M., Alatrach, M., Abubaker, J. A., Al‐Khairi, I., Cherian, P., Agyin, K., Abdelgani, S., Norton, L., Adams, J., Alsaeed, D., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3643 · Cited by 4
Lipid disorders in children and adolescents
Daniels, S. R., & Couch, S. C. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00032-9 · Cited by 4
Familial Hypercholesterolemia: Update and Review
Chacon-Camacho, O. F., Pozo‐Molina, G., Méndez-Catalá, C. F., Reyes‐Reali, J., Méndez-Cruz, R., & Zenteno, J. C. (2021) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530321666210208212148 · Cited by 4
Koshevoy, V., Викулина, Г. В., & Naumenko, S. V. (2023) · Bulletin Veterinary biotechnology · doi:10.31073/vet_biotech43-08 · Cited by 4
Evans, D., Beil, F. U., & Aberle, J. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.09.006 · Cited by 6
Causal relationship between plasma lipidome and rosacea: a Mendelian randomization analysis
Wang, X., & Zhu, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1427656 · Cited by 3
Hypertension, Atherosclerosis and Dyslipidemias
Carlberg, C., Ulven, S. M., & Molnár, F. (2016) · Springer eBooks · doi:10.1007/978-3-319-30415-1_11 · Cited by 3
From Genetic Findings to new Intestinal Molecular Targets in Lipid Metabolism
May, C. L., Ducheix, S., Cariou, B., & Rimbert, A. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01264-w · Cited by 3
Adeli, K., Xiao, C., Higgins, V., Taher, J., Farr, S., & Lewis, G. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824048-9.00002-x · Cited by 3
FISIOPATOLOGIA E TRATAMENTOS ATUALMENTE DISPONÍVEIS PARA DISLIPIDEMIA
Almeida, A. B., Pontes, B. B., Gioia, L. N., & Rangel, V. (2023) · EPITAYA eBooks · doi:10.47879/ed.ep.2023809p32 · Cited by 3
Colic, M., Pantović, S., Jeremić, M., Joković, V., Obradovic, Z., & Rosic, M. A. (2015) · Circulation Journal · doi:10.1253/circj.cj-14-1316 · Cited by 3
Lipoprotein metabolism differs between Marek's disease susceptible and resistant chickens
Yuan, P., Yu, Y., Luo, J., Tian, F., Zhang, H., Chang, S., Ramachandran, R., Zhang, L., & Song, J. (2012) · Poultry Science · doi:10.3382/ps.2011-01843 · Cited by 3
The application of gene therapy in lipid disorders: where are we now?
Dubé, J. B., & Hegele, R. A. (2012) · Clinical Lipidology · doi:10.2217/clp.12.42 · Cited by 3
Self-citationDiagnosis and Treatment of Dyslipoproteinemias in Children and Adolescents
Kwiterovich, P. O., & Byrne, K. (2013) · Humana Press eBooks · doi:10.1007/978-1-60761-395-4_30 · Cited by 3
Robert, J., Cheng, W. H., Hayat, A., Ward-Able, T., & Wellington, C. L. (2015) · Clinical Lipidology · doi:10.2217/clp.14.64 · Cited by 3
Exautomate: A user-friendly tool for region-based rare variant association analysis (RVAA)Preprint
Davis, B. D., Dron, J. S., Robinson, J. F., Hegele, R. A., & Lizotte, D. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/649368 · Cited by 5
Self-citationvan Lith, H. A., Laarakker, M. C., Klooster, J. G. L. T., & Ohl, F. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1078-z · Cited by 2
Galán, D. C. C., Coy, A., Lizcano, C. A. R., & Rojas, W. (2022) · Revista Repertorio de Medicina y Cirugía · doi:10.31260/repertmedcir.01217372.1015 · Cited by 2
AAV8- LDLR Gene Therapy in Ldlr -KO and Homozygous Ldlr p.W483X Mice
Li, Q., Tang, M., Jin, Y., Ju, K., Li, Y., Ju, K., Zhang, S., Zhang, S., & Luan, X. (2025) · Human Gene Therapy · doi:10.1089/hum.2024.164 · Cited by 2
Fang, W., Zhao, H., Zhang, Y., Bai, S., Luo, Y., Han, R., Yang, Z., Cheng, B., Qian, C., & Du, J. (2026) · ACS Nano · doi:10.1021/acsnano.5c22179 · Cited by 3
Oxidized Lipoproteins as the Diagnostic Target for Cardiovascular Diseases
Sreeja, S., Manoharan, A., & Venkataraman, K. (2018) · Current Science · doi:10.18520/cs/v115/i7/1276-1286 · Cited by 2
Gülersoy, E., İyigün, S. S., & Güzelbekteş, H. (2022) · Erciyes Üniversitesi Veteriner Fakültesi Dergisi · doi:10.32707/ercivet.1142535 · Cited by 2
Inherited atherogenic dyslipidemias: are they correctly reported?
Sampietro, T., Pieroni, S., Molinaro, S., Sbrana, F., Pino, B. D., Bigazzi, F., Ruscica, M., Sirtori, C. R., & Franchini, M. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320930308 · Cited by 2
Katona, T. M., & Smoller, B. R. (2010) · Springer eBooks · doi:10.1007/978-1-60761-181-3_6 · Cited by 2
Short‐term impact of vitamin K2 supplementation on biochemical parameters and lipoprotein fractions
Barna, M., Dunovská, K., Čepová, J., Werle, J., Průša, R., Bjørklud, G., Melicherčík, P., Kizek, R., & Klapková, E. (2024) · Electrophoresis · doi:10.1002/elps.202400058 · Cited by 2
Genetics paired with CT angiography in the setting of atherosclerosis
Li, D., & Budoff, M. J. (2016) · Clinical Imaging · doi:10.1016/j.clinimag.2016.04.005 · Cited by 2
Molecular Diagnosis in the Post Genomic and Proteomic Era
Debnath, M., Prasad, G. B. K. S., & Bisen, P. S. (2009) · Springer eBooks · doi:10.1007/978-90-481-3261-4_7 · Cited by 2
Suchánek, P., Lánská, V., Stávek, P., & Hubacek, J. A. (2021) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/129574 · Cited by 2
Rodríguez, A., & Kwiterovich, P. O. (2011) · Springer eBooks · doi:10.1007/978-3-642-15720-2_32 · Cited by 2
Brahm, A. J., & Hegele, R. A. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_11 · Cited by 2
Self-citationCakmak, B., Yeral, S., Ozcan, B., Parıltay, E., Ozgul, S., Şimşir, İ. Y., & Hegele, R. A. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.09.015 · Cited by 2
Self-citationVariación genética de lipoproteínas y lípidos plasmáticos
Santos, J. L. (2010) · Revista chilena de cardiología · doi:10.4067/s0718-85602010000100009 · Cited by 2
Krasi, G., Bushati, V., Precone, V., Cortese, B., Agostini, F., Tezzele, S., Baglivo, M., Cecchin, S., Aquilanti, B., Velluti, V., et al. (2019) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v90i10-s.8757 · Cited by 2
Low HDL and High HDL Syndromes
Yamashita, S., & Matsuzawa, Y. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.04000-9 · Cited by 2
Vernardis, S. I., Demichev, V., Lemke, O., Grüning, N., Messner, C. B., White, M. E. H., Pietzner, M., Peluso, A., Collet, T., Henning, E., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1363070/v1 · Cited by 2
Food Metabolism and Chronic Diseases
Tiwari, R., Yadav, A., Hamsa, S., & Dhewa, T. (2023) · Wiley eBooks · doi:10.1002/9781394229116.ch16 · Cited by 2
Cholesterol Metabolism: An Ally in the Development and Progression of Cervical Cancer
Martínez-Ramírez, I., Muñoz-Bello, J. O., Contreras‐Paredes, A., Parra-Hernández, E., Carrillo‐García, A., & Lizano, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020591 · Cited by 1
HYPERTRIGLYCERIDEMIA AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASES
NURIEVA, L. M., KIM, Z. F., GALYVICH, A. S., & Sadykova, D. I. (2023) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2023.16(4).104-110 · Cited by 1
Wang, X., Qin, S., Xiang, H., Tao, Y., Chen, S., & Lu, H. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02932-3 · Cited by 1
Hill, S. E. (2009) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
CETP Inhibitors: Will They Live up to Their Promise?
Cheung, V., & Hegele, R. A. (2011) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-011-0206-0 · Cited by 1
Self-citationGenetic determinants of lipid homeostasis
Young, E. H., Papamarkou, T., Wainwright, N. W. J., & Sandhu, M. S. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.11.004 · Cited by 1
APOE −491 T allele may reduce the risk of atherosclerotic lesions among middle-aged women
Bañares, V. G., Bardach, A., Peterson, G., Tavella, M. J., & Schreier, L. E. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1134-5 · Cited by 1
Integrated approaches to functionally characterize novel factors in lipoprotein metabolism
Runz, H. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328350fc3d · Cited by 1
Wcisło, G., & Szarlej-Wcisło, K. (2016) · Elsevier eBooks · doi:10.1016/b978-1-63067-036-8.00029-9 · Cited by 1
THE ROLE OF PXR AND IKKβ SIGNALING IN CARDIOMETABOLIC DISEASE
Helsley, R. N. (2016) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2016.040 · Cited by 1
Personalized Diet and Lifestyle Interventions on Lipids and Lipoproteins
Zheng, Y., & Qi, L. (2016) · Elsevier eBooks · doi:10.1016/b978-1-63067-036-8.00001-9 · Cited by 1
Журба, О. М., Merinov, A. V., Алексеенко, А. Н., & Валерьевна, К. И. (2021) · Hygiene and Sanitation · doi:10.47470/0016-9900-2021-100-12-1430-1435 · Cited by 1
Blanco, A., & Blanco, G. V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91599-1.00014-6 · Cited by 1
Evaluation of lipid profile in patients with cherry angioma: A case–control study in Iraqi patients
Al-Hattab, M. K., Gahlool, A. H., & Al-Kalidi, J. H. (2024) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_552_23 · Cited by 1
Hypertriglyceridemia: diagnostic issues, therapeutic strategies
Bakaleiko, V. V., Reutova, O. V., Алиева, М. С., Baratashvili, G. G., Kostareva, A. A., & Alieva, A. S. (2024) · Russian Journal for Personalized Medicine · doi:10.18705/2782-3806-20244-3-194-205 · Cited by 1
Detection and Treatment of Children and Adolescents with Dyslipidemia
Kwiterovich, P. O. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_5 · Cited by 1
Nutritional Interventions to Lower Cholesterol and Risk for Heart Disease in Children
Daniels, S. R., Hildebrandt, J., Brennan, L. K., & Couch, S. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-43027-0_12 · Cited by 1
Investigated treatments for lipoprotein lipase deficiency and related metabolic disorders
Lee, J.-H., & Hegele, R. A. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1311784 · Cited by 1
Self-citationLeón, A. S., Bernstein, C. N., El-Gabalawy, H. S., & Eck, P. (2018) · Clinical Nutrition and Metabolism · doi:10.15761/cnm.1000106 · Cited by 1
Exclusion of Dietary Cholesterol from The Specific Food Restrictions: A Review in Indonesia
Zulkarnain, M. R. (2018) · Jurnal Sains Boga · doi:10.21009/jsb.001.1.01 · Cited by 1
Progress of Genomics in Atherosclerosis-Coronary Heart Disease and Myocardial Infarction
Yuan, J., & Liu, Y. (2018) · Translational bioinformatics · doi:10.1007/978-981-13-1429-2_8 · Cited by 1
Complejidad de la expresión de genes asociados a obesidad en el tejido adiposo humano
Rodríguez, A., Echandía, C. A., Sánchez, A., Satizábal, J. M., Montoya, J. C., & Vallejo, F. G. (2019) · Revista Med · doi:10.18359/rmed.3978 · Cited by 1
Onadeko, O. T., Okunowo, W. O., Imaga, N. A., Abdulrazaq, M. M., Onuminya, O. J., Van-lare, T. O., & Nwosu, M. (2020) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2020.101687 · Cited by 1
Meisenberg, G., & Simmons, W. H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-07155-0.00025-3 · Cited by 1
Clinical Evaluation for Genetic and Secondary Causes of Dyslipidemia
Creider, J. C., & Hegele, R. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00011-6 · Cited by 1
Self-citationHyperchylomicronemia: a neglected disease?
Vigna, G. B., & Fellin, R. (2009) · Italian Journal of Medicine · doi:10.1016/j.itjm.2009.05.002 · Cited by 1
Genetic Loci Influencing Plasma High Density Lipoprotein Cholesterol Concentrations in Humans
Brousseau, M. E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1059-2_14 · Cited by 1
Atherosclerosis: Cholesterol Management
Edmondson, S. D., Burnett, D. A., & Davis, H. R. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc185.pub2 · Cited by 1
Elucidating the genetic determinants of the archetypal complex disease hypertriglyceridemia
Johansen, C. T. (2011) · Scholarship@Western (Western University)
Identification of loci for migraine with aura
Tikka-Kleemola, P. (2009) · Työväentutkimus Vuosikirja
THE EFFECTS OF HYPOMORPHIC SIALIDASE EXPRESSION ON ATHEROSCLEROSIS
Yang, A. (2012) · MacSphere (McMaster University) · doi:10.71548/14532
Recherche de déterminants génétiques des phénotypes associés au syndrome métabolique en population
Legry, V. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Simmons, C. R. (2011) · UKnowledge (University of Kentucky)
Mechanisms for low density lipoprotein receptor internalization
Kang, Y.-L. (2013) · University of Minnesota Digital Conservancy (University of Minnesota)
Regulatory Immune Responses and Repair Mechanisms in Atherosclerosis
Rattik, S. (2015) · Lund University Publications (Lund University)
IL-25 and B cells in atherosclerosis
Mantani, P. T. (2014)
Shami, A. (2014) · Lund University Publications (Lund University)
The molecular basis of early onset cardiovascular disease
Sivapalaratnam, S. (2012) · UvA-DARE (University of Amsterdam)
Genetic risk factors for stroke in the genome-wide association era
Patel, N., Lanktree, M. B., & Hegele, R. A. (2010) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2011.540567
Self-citationHypertriglyceridaemia in a case of antenatal Bartter syndrome type I
Ding, W. Y., Dudley, J., & Jadresic, L. P. (2014) · Research · doi:10.13070/rs.en.1.1085
Genetic defects in triacylglycerol and cholesterol uptake
Stanley, J. C. (2011) · Lipid Technology · doi:10.1002/lite.201100103
Hypertriglyceridemia: the future of genetics to guide individualized therapeutic strategies
Moens, S. J. B., Hassing, C., Nieuwdorp, M., Stroes, E. S. G., & Dallinga‐Thie, G. M. (2013) · Clinical Lipidology · doi:10.2217/clp.13.23
Kim, S., Shin, C., Cho, N. H., Koh, I., Ko, J., & Kwack, K. (2014) · Genes & Genomics · doi:10.1007/s13258-014-0216-7
Dissecting lipid and lipoprotein issues in women: anin utero-through-menopause journey
Dayspring, T. D., & Baum, S. J. (2015) · Clinical Lipidology · doi:10.2217/clp.15.28
Piovezan, M. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Magister, M. D. (2013)
Genetics of Cardiovascular Risk in Obesity
Blackett, P. R., & Sanghera, D. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_13-1
Lee, J. W. (2013) · OUKA (Osaka University Knowledge Archive) (Osaka University) · doi:10.18910/26183
Metadata
- Authors
- Hegele, R. A.
- Affiliations
- Western University (CA)
- Corresponding author
- Hegele, Robert A.
- ORCID
- Hegele, Robert A.
- Venue
- Nature Reviews Genetics
- Published
- 2009-02
- Volume
- 10
- Issue
- 2
- Pages
- 109-121
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W2068700927
- Cited by
- 462
- References
- 107
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 19 · 2023: 21 · 2022: 32 · 2021: 22 · 2020: 24 · 2019: 19 · 2018: 27 · 2017: 19 · 2016: 31 · 2015: 33 · 2014: 36 · 2013: 26 · 2012: 31
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- serum lipoproteins, plasma lipids, genetic architecture, cardiovascular risk, dyslipidemia, genome-wide association study, rare variants, lipid metabolism, metabolic networks, phenomics, resequencing, disease diagnosis and treatment
- MeSH terms
- Animals, Cholesterol, Humans, Hyperlipoproteinemias, Lipoproteins, Models, Biological, Triglycerides, Genomics, Dyslipidemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review